Johnson & Johnson to Buy Proteologix For $850 Million in Cash
Johnson & Johnson (JNJ) has agreed to acquire privately held biotechnology firm Proteologix for $850 million in cash, the companies said Thursday. The healthcare products conglomerate said the acquisi
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Thursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cas
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition
Johnson & Johnson (JNJ) said Monday it is offering its senior unsecured notes in four tranches to help fund its planned acquisition of Shockwave Medical (SWAV). Closing of the deal is subject to appro
Maintaining Hold: Shockwave Medical's Solid Performance Tempered by Market Valuation
Shockwave Medical's High Stakes: The Cost of a Collapsed Johnson & Johnson Merger
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
Hold Rating Justified for Shockwave Medical Amidst Strong Performance and Pending Johnson & Johnson Acquisition
Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Shockwave Medical Surpasses Analyst Revenue Forecasts in Q1 2024
ShockWave Medical | 10-Q: Quarterly report
Shockwave Medical: Given the Proposed Acquisition by Johnson & Johnson, Shockwave Medical Is Withdrawing Its Full Yr 2024 Guidance Previously Issued on Feb 15 >SWAV
Shockwave Medical: Given the Proposed Acquisition by Johnson & Johnson, Shockwave Medical Is Withdrawing Its Full Yr 2024 Guidance Previously Issued on Feb 15 >SWAV
Shockwave Medical 1Q Net $55.3M >SWAV
Shockwave Medical 1Q Net $55.3M >SWAV
Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result
Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE:JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost
Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Shockwave Medical (SWAV) Rose on Strong Financial Results
No Data